Wealthcare Advisory Partners LLC Astrazeneca PLC Transaction History

Wealthcare Advisory Partners LLC

$3.43 Billion
Q3 2024

A detailed history of Wealthcare Advisory Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 5,660 shares of AZN stock, worth $364,730. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,660

Previous 5,858 3.38%

Holding current value

$364,730

Previous $456,000 3.29%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$76.67 - $87.62 $15,180 - $17,348	-198 Reduced 3.38%	5,660 $441,000
Q2 2024 Aug 09, 2024	SELL	$66.81 - $80.83 $18,573 - $22,470	-278 Reduced 4.53%	5,858 $456,000
Q1 2024 Apr 15, 2024	BUY	$61.03 - $69.57 $33,139 - $37,776	543 Added 9.71%	6,136 $415,000
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $77,176 - $86,392	-1,247 Reduced 18.23%	5,593 $376,000
Q3 2023 Oct 12, 2023	SELL	$64.85 - $71.7 $14,266 - $15,774	-220 Reduced 3.12%	6,840 $463,000
Q2 2023 Jul 17, 2023	SELL	$69.91 - $75.81 $21,811 - $23,652	-312 Reduced 4.23%	7,060 $505,000
Q1 2023 May 04, 2023	SELL	$63.15 - $71.6 $23,681 - $26,849	-375 Reduced 4.84%	7,372 $511,000
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $14,961 - $19,441	276 Added 3.69%	7,747 $525,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $48,725 - $124,754	919 Added 14.03%	7,471 $410,000
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $15,289 - $18,354	-258 Reduced 3.79%	6,552 $433,000
Q1 2022 Apr 15, 2022	SELL	$55.72 - $67.12 $24,349 - $29,331	-437 Reduced 6.03%	6,810 $452,000
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $30,845 - $36,446	571 Added 8.55%	7,247 $422,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $96,674 - $105,774	1,740 Added 35.25%	6,676 $401,000
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $17,673 - $21,965	-365 Reduced 6.89%	4,936 $296,000
Q1 2021 Apr 30, 2021	BUY	$47.16 - $54.44 $36,360 - $41,973	771 Added 17.02%	5,301 $264,000
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $14,070 - $16,825	-290 Reduced 6.02%	4,530 $226,000
Q3 2020 Oct 29, 2020	BUY	$53.07 - $61.1 $30,090 - $34,643	567 Added 13.33%	4,820 $264,000
Q2 2020 Jul 29, 2020	BUY	$43.1 - $55.31 $12,930 - $16,593	300 Added 7.59%	4,253 $225,000
Q1 2020 Apr 29, 2020	BUY	$37.79 - $51.33 $12,659 - $17,195	335 Added 9.26%	3,953 $177,000
Q3 2019 Oct 17, 2019	BUY	$40.12 - $45.47 $11,995 - $13,595	299 Added 9.01%	3,618 $161,000
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $27,895 - $33,813	-786 Reduced 19.15%	3,319 $134,000
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $24,954 - $28,088	-677 Reduced 14.16%	4,105 $156,000
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $10,365 - $11,115	300 Added 6.69%	4,782 $168,000
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $37,091 - $41,208	-1,125 Reduced 20.06%	4,482 $157,000
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $5,840 - $6,329	182 Added 3.35%	5,607 $195,000
Q3 2017 Nov 15, 2017	BUY	$28.96 - $34.0 $157,108 - $184,450	5,425	5,425 $184,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.

Account

Wealthcare Advisory Partners LLC Astrazeneca PLC Transaction History